knowledge -WSS

knowledge

author：knowledge 2025-08-12 09:09:18 - browse：81

Researchers say they’ve been able to measure recovery from treatment-resistant depression through brain scans — a crucial step toward quantifying the impact of therapies on a condition whose progress is notoriously difficult to measure objectively. And that’s thanks to generative AI, they say.

In a small study published Wednesday — just 10 people with severe, treatment-resistant depression receiving deep brain stimulation therapy — researchers used the electrodes to record brain activity and later fed the scans into a homegrown artificial intelligence system that analyzed them for patterns. They found that it was possible to track patients’ recovery through changes in brain cells’ electrical activity.

Finding so-called biomarkers, or objective measurements reflecting depression, could help diagnose depression, track its progression, predict a relapse, and better tailor therapies to individual patients. But finding those metrics has been difficult, partly because depression’s biological impact isn’t well understood.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： The high cost of giving birth even with insurance
Next article： JPM 2024: Nvidia claims we're in biological revolution. Are we?

explore

WSS

The SUPPORT Act is critical to fighting the opioid crisis

Health and fitness trackers are measuring the wrong things

Medicare drug price negotiation hearing pits pharma v Biden admin

Why liver experts renamed NASH to MASH, and NAFLD to MASLD

As JPM 2024 winds down, some health tech firms project optimism

The public health thinking behind the CDC’s new Covid guidance

hotspot

knowledge

hotspot

The high cost of giving birth even with insurance

Heart disease and mental health: A look at cardiac psychology

The cancer drug shortage isn’t new — and neither are the solutions

GSK to buy asthma

Supreme Court strikes down use of affirmative action

State of the Union pitch: Bigger Medicare drug price negotiations

Drug repurposing or repositioning? The language matters

Lack of health data on LGBTQ+ people has serious consequences

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Florida health officials providing scant details on measles cases

Wikipedia

Streamlined flu vaccines recommended by FDA advisory panel

GSK to buy asthma

Ancient Greek ideas underpin modern concepts of pregnancy

Medicare drug price negotiation continues, as pharma counteroffers

Immune cells and nerve overgrowth may explain recurring UTI pain

Change Healthcare: What is it, why does its cyberattack matter?

knowledge

explore

focus

hotspot